Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Net Asset Quality Index
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Net Asset Quality Index of 16.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.56 Billion minus total liabilities of CN¥2.13 Billion yields net assets of CN¥429.55 Million. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Hainan Huluwa Pharmaceutical Group Co Lt to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hainan Huluwa Pharmaceutical Group Co Ltd Net Asset Quality Index Over Time (2016–2025)
This chart shows how Hainan Huluwa Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 16.8%, representing net assets of CN¥429.55 Million against total assets of CN¥2.56 Billion CNY. Explore Hainan Huluwa Pharmaceutical Group Co Lt operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Hainan Huluwa Pharmaceutical Group Co Lt market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 17.6% | CN¥458.02 Million | CN¥2.60 Billion | CN¥2.14 Billion | ▼ -7.5 pp |
| 2024 | 25.1% | CN¥743.28 Million | CN¥2.96 Billion | CN¥2.22 Billion | ▼ -12.8 pp |
| 2023 | 37.9% | CN¥1.16 Billion | CN¥3.06 Billion | CN¥1.90 Billion | ▼ -6.0 pp |
| 2022 | 43.9% | CN¥1.02 Billion | CN¥2.31 Billion | CN¥1.30 Billion | ▼ -8.9 pp |
| 2021 | 52.8% | CN¥930.52 Million | CN¥1.76 Billion | CN¥830.41 Million | ▼ -7.4 pp |
| 2020 | 60.2% | CN¥916.48 Million | CN¥1.52 Billion | CN¥604.68 Million | ▲ +1.0 pp |
| 2019 | 59.3% | CN¥643.94 Million | CN¥1.09 Billion | CN¥442.67 Million | ▲ +3.9 pp |
| 2018 | 55.4% | CN¥604.61 Million | CN¥1.09 Billion | CN¥487.37 Million | ▲ +11.8 pp |
| 2017 | 43.5% | CN¥351.38 Million | CN¥807.21 Million | CN¥455.83 Million | ▲ +19.5 pp |
| 2016 | 24.0% | CN¥128.69 Million | CN¥535.95 Million | CN¥407.26 Million | — |